- Abstract Number: 2453
Gastrointestinal Symptom Severity and Intestinal Permeability in Systemic Sclerosis: A Single Center Prospective Study
- Abstract Number: 1337
Gender and Ethnic Differences (or Lack Thereof) in Perceived Disease Burden in RA
- Abstract Number: 0578
Gender Differences in Disease Parameters, Adherence to Treat to Target Strategy and Outcomes in Axial Spondyloarthritis (axSpA) in Pakistani Cohort
- Abstract Number: 1498
Gender Disparities in Clinical Manifestations and Outcomes of Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis
- Abstract Number: 1025
Gender Disparities in Disease Impact and Treatment Access for Spondyloarthropathies in Latin America: Insights from a Web Survey
- Abstract Number: 0571
Gender-specific Performance of Disease Activity Assessment Tools in Axial Spondyloarthritis: Ancillary Analysis of the PREDICT-SpA Study
- Abstract Number: 2567
Gene Expression in Osteonecrosis of the Femoral Head: A Region-matched RNA-sequencing Study
- Abstract Number: 2316
Gene Expression Profile Is Different Between Men and Women in Psoriatic Disease
- Abstract Number: 2481
General, Nervous System, Eye, and Skin Involvement in the Phase 3 Trial of Avacopan for the Treatment of ANCA-Associated Vasculitis
- Abstract Number: 0922
Generation and Pathophysiological Analysis of M694I Variant Knock-in Mice of Human MEFV Gene: Insights from Single-Cell RNA Sequencing
- Abstract Number: 2139
Generation of a Human 3D Bone Model to Mimic Glucocorticoid- induced Osteoporosis In Vitro
- Abstract Number: 0884
Genetic Architecture Divergence in Sjögren’s Disease Subphenotypes and Populations: Genome-wide Association Study of Ro/SSA+ and Ro/SSA- Cases in European Populations
- Abstract Number: 1485
Genetic Contributions to Systemic Lupus Erythematosus: Concordance Rates in California Twins
- Abstract Number: 0628
Genetic Determinants of Childhood Onset Systemic Lupus Erythematosus
- Abstract Number: 0888
Genetically Determined Peptidylglycine Alpha-amidating Monooxygenase (PAM) Mediated Amidation Regulates Tissue Damage by Rheumatoid Arthritis Synovial Fibroblasts
- Abstract Number: 2049
Genetically Proxied Glucose‑lowering Drug Target and Risk of Immune Mediated Inflammatory Disease: A Mendelian Randomization Study
- Abstract Number: 1355
Genetically-determined Variation in C-reactive Protein Impacts Disease Activity Assessment in Rheumatoid Arthritis
- Abstract Number: 2632
Genetically-engineered Ro-specific Regulatory T Cells to Treat Primary Sjögren’s Disease
- Abstract Number: 1803
Genetics of eGFR Variability as a Proxy for Lupus Nephritis in Patients with Systemic Lupus Erythematosus
- Abstract Number: 2602
Genetics of Sex Dimorphism in Clinical Manifestations of Systemic Lupus Erythematosus
- Abstract Number: 2533
Genome-wide Association of Rheumatoid Arthritis in the African Ancestry Identifies HLA Amino Acid Polymorphisms of Risk
- Abstract Number: 1829
Genomic Analysis of Skin Biopsies Differentiates Major Anti-Nuclear Autoantibody Subsets in Limited Cutaneous Systemic Sclerosis
- Abstract Number: 0997
Geographic and Lifestyle Exposures in Systemic Lupus Erythematosus
- Abstract Number: 1637
Giant Cell Arteritis-Polymyalgia Rheumatica Spectrum Disease: Relation with Neoplasms and Role as a Paraneoplastic Syndrome
- Abstract Number: 0549
Global Distribution and Determinants of Diagnostic Delay Across Diverse Spondyloarthritis Entities: Data from the International ASAS-Perspa Study
- Abstract Number: 2041
Global Prevalence and Clinical Outcomes of Cogan Syndrome
- Abstract Number: 0772
Global Recruiting Patterns Are Associated with Placebo Response Rates in Clinical Trials of Psoriatic Arthritis
- Abstract Number: 1746
Global Recruiting Patterns Are Associated with Placebo Response Rates in Clinical Trials of Rheumatoid Arthritis
- Abstract Number: 0226
Global Ultrasound Scoring Systems for Assessing Synovitis in Rheumatoid Arthritis
- Abstract Number: 0728
Glomerular Proteomic Signature in ANCA-associated Glomerulonephritis
- Abstract Number: 2576
Glucagon-Like Peptide-1 Receptor Agonist Use and the Risk of Adverse Cardiac and Kidney Outcomes Among Patients with Systemic Lupus Erythematosus and Lupus Nephritis
- Abstract Number: 2141
Glucocorticoid Therapy-Associated Bone Fractures Are Associated with Osteoporosis Underscreening in Patients with Rheumatoid Arthritis
- Abstract Number: 0810
Glucocorticoids in Pregnancy and Lactation: Results of the Systematic Review Informing the EULAR Task Force on Antirheumatic Drugs in Reproduction, Pregnancy and Lactation
- Abstract Number: 2486
Glucocorticoids May Mitigate the Risk of Avacopan-Induced Liver Dysfunction in ANCA-Associated Vasculitis: Data from a Multicenter Observational Study in Japan
- Abstract Number: 1599
Glucocorticoids versus Glucocorticoids Plus Cyclophosphamide in Eosinophilic Granulomatosis with Polyangiitis with Poor-Prognosis Factors: A Target Trial Emulation Study
- Abstract Number: 1600
Glucocorticoids versus Glucocorticoids Plus Cyclophosphamide in Eosinophilic Granulomatosis with Polyangiitis Without Poor-Prognosis Factors: A Target Trial Emulation Study
- Abstract Number: 1812
Glycosylation Changes as Non-Invasive Biomarkers for Lupus Nephritis Detection and Prognosis
- Abstract Number: 1289
Gout Education for Primary Care Providers: A Scoping Review
- Abstract Number: 2006
Gout Flares After Stopping Anti-inflammatory Prophylaxis During the Early Phases of Urate-Lowering Therapy
- Abstract Number: 1992
Gout FlaresFollowingImmune Checkpoint Inhibitors Treatment
- Abstract Number: 1996
Granulomatous Reactions in Cancer Patients Treated with Immune Checkpoint Inhibitors: A Systematic Literature Review
- Abstract Number: 1912
Greater Glucocorticoid and Less Biologic/Targeted Therapy Use in Midwest PsA Patients Despite Prevalent Comorbidity
- Abstract Number: 0422
Greater Use of Assisted Reproductive Techniques but Comparable Obstetric Morbidity in a Population of Women with Spondyloarthritis: A Matched Comparative Analysis of the GR2 Prospective Cohort and the French National Perinatal Surveys
- Abstract Number: 2542
Group 2 Innate Lymphoid Cells Aggravates Development of Inflammatory Arthritis
- Abstract Number: 0938
Group 2 Innate Lymphoid Cells Promote T Cell Activation and Development of Autoimmune Arthritis
- Abstract Number: 1571
Growth Differentiation Factor 15 Is a Serum Biomarker and Pathogenic Factor of Progressive Fibrosis in Systemic Sclerosis
- Abstract Number: 2204
Guidance for Stem Cell Therapy for Juvenile Systemic Sclerosis Patients
- Abstract Number: 1132
Guselkumab and Golimumab Combination Induction Therapy in Ulcerative Colitis Results in Early Local Tissue Healing That Is Sustained Through Guselkumab Maintenance Therapy
- Abstract Number: 2585
Guselkumab and IL-17 Inhibitors Improve Patient-perceived Impact of Psoriatic Arthritis Similarly: 6-month Interim Results of the PsABIOnd Observational Cohort Study
- Abstract Number: 1464
Guselkumab and IL-17 Inhibitors Show Comparable Treatment Persistence and Effectiveness in Psoriatic Arthritis: 6-month Interim Results of the PsABIOnd Observational Cohort Study
- Abstract Number: 0605
Guselkumab Binding to CD64+ IL-23–Producing Myeloid Cells Enhances Potency for Neutralizing IL-23 Signaling
- Abstract Number: 2342
Guselkumab Shows Similar Domain-Specific Efficacy in Females and Males with Active Psoriatic Arthritis: Post Hoc Analyses of Three Phase 3, Randomized, Double-blind, Placebo-Controlled Studies
ACR Convergence 2024
November 14-19, 2024. Washington, DC.